Oup Management Co., LLC has filed its 13F form on November 09, 2023 for Q3 2023 where it was disclosed a total value porftolio of $44.5 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Centessa Pharmaceuticals PLC with a value of $19M, Aerovate Therapeutics, Inc. with a value of $8.19M, Cyteir Therapeutics, Inc. with a value of $6.99M, Pmv Pharmaceuticals, Inc. with a value of $6.07M, and Graphite Bio, Inc. with a value of $1.01M.

Examining the 13F form we can see an decrease of $14.2M in the current position value, from $58.6M to 44.5M.

Below you can find more details about Oup Management Co., LLC portfolio as well as his latest detailed transactions.

Portfolio value $44.5 Million
Healthcare: $44.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 12
  • Current Value $44.5 Million
  • Prior Value $58.6 Million
  • Filing
  • Period Q3 2023
  • Filing Date November 09, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Oup Management Co., LLC Portfolio

Follow Oup Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.


Stay updated on Oup Management Co., LLC with notifications on news.